Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate , 97% , 503614-91-3

CAS NO.：503614-91-3

Empirical Formula: C27H28N4O5

Molecular Weight: 488.54

MDL number: MFCD18072444

EINECS: 700-890-7

PRODUCT Properties

• Melting point: 175 - 180°C
• Boiling point: 758.7±60.0 °C(Predicted)
• Density: 1.34
• vapor pressure: 0.001Pa at 25℃
• storage temp.: Sealed in dry,Room Temperature
• solubility: Chloroform (Slightly), Methanol (Slightly)
• pka: 0.78±0.20(Predicted)
• form: Solid
• color: White to Pale Beige
• InChI: InChI=1S/C27H28N4O5/c1-3-36-27(34)24-22-15-17-30(19-9-7-18(8-10-19)29-16-5-4-6-23(29)32)26(33)25(22)31(28-24)20-11-13-21(35-2)14-12-20/h7-14H,3-6,15-17H2,1-2H3
• InChIKey: PULNLYVCJSOXKS-UHFFFAOYSA-N
• SMILES: C1(=O)N(C2=CC=C(N3CCCCC3=O)C=C2)CCC2C(C(OCC)=O)=NN(C3=CC=C(OC)C=C3)C1=2
• LogP: 172 at 22.8℃

Description and Uses

Apixaban V is a derivative of Apixaban (A726700), a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. It is a potential new oral coagulant that may be useful prevention of venous thromboembolism in total hip, knee replacement orthopedic surgery and stroke in treatment of patient with venous thromboembolic disorder or with atrial fibrillation

Safety

• Hazard statements: H412
• Precautionary statements: P273-P501